首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
INFLUENCE OF INFUSION METHOD ON SERUM TOBRAMYCIN CONCENTRATIONS IN ADULTS WITH CYSTIC-FIBROSIS
被引:0
|
作者
:
PLEASANTS, RA
论文数:
0
引用数:
0
h-index:
0
PLEASANTS, RA
WILLIAMS, DM
论文数:
0
引用数:
0
h-index:
0
WILLIAMS, DM
WALTNER, WE
论文数:
0
引用数:
0
h-index:
0
WALTNER, WE
KNOWLES, MR
论文数:
0
引用数:
0
h-index:
0
KNOWLES, MR
机构
:
来源
:
CLINICAL PHARMACY
|
1990年
/ 9卷
/ 07期
关键词
:
D O I
:
暂无
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:541 / 545
页数:5
相关论文
共 50 条
[1]
ABSOLUTE BIOAVAILABILITY OF INHALED TOBRAMYCIN IN ADULTS WITH CYSTIC-FIBROSIS
COONEY, GF
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
COONEY, GF
TOMASELLI, M
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
TOMASELLI, M
LUM, BL
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
LUM, BL
FIEL, SB
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
FIEL, SB
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1992,
51
(02)
: 181
-
181
[2]
DOSING OF TOBRAMYCIN IN CHILDREN WITH CYSTIC-FIBROSIS USING SERUM CONCENTRATIONS .2. PHARMACODYNAMICS
HORREVORTS, AM
论文数:
0
引用数:
0
h-index:
0
机构:
ERASMUS UNIV,DEPT CLIN MICROBIOL,3000 DR ROTTERDAM,NETHERLANDS
HORREVORTS, AM
DRIESSEN, O
论文数:
0
引用数:
0
h-index:
0
机构:
ERASMUS UNIV,DEPT CLIN MICROBIOL,3000 DR ROTTERDAM,NETHERLANDS
DRIESSEN, O
DEWITTE, J
论文数:
0
引用数:
0
h-index:
0
机构:
ERASMUS UNIV,DEPT CLIN MICROBIOL,3000 DR ROTTERDAM,NETHERLANDS
DEWITTE, J
MICHEL, MF
论文数:
0
引用数:
0
h-index:
0
机构:
ERASMUS UNIV,DEPT CLIN MICROBIOL,3000 DR ROTTERDAM,NETHERLANDS
MICHEL, MF
KERREBIJN, KF
论文数:
0
引用数:
0
h-index:
0
机构:
ERASMUS UNIV,DEPT CLIN MICROBIOL,3000 DR ROTTERDAM,NETHERLANDS
KERREBIJN, KF
PEDIATRIC RESEARCH,
1986,
20
(10)
: 1047
-
1047
[3]
DOES TOBRAMYCIN CLEARANCE DIFFER IN ADULTS WITH CYSTIC-FIBROSIS
COONEY, GF
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
COONEY, GF
ROCCI, ML
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
ROCCI, ML
FIEL, SB
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
FIEL, SB
BOCZAR, KE
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
BOCZAR, KE
LAZIN, BM
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19122
LAZIN, BM
PHARMACOTHERAPY,
1988,
8
(02):
: 124
-
124
[4]
DOES TOBRAMYCIN CLEARANCE DIFFER IN ADULTS WITH CYSTIC-FIBROSIS
COONEY, GF
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
COONEY, GF
ROCCI, ML
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
ROCCI, ML
FIEL, SB
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
FIEL, SB
BOCZAR, KE
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
BOCZAR, KE
LAZIN, BM
论文数:
0
引用数:
0
h-index:
0
机构:
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
TEMPLE UNIV HOSP,JEFFERSON MED COLL,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19140
LAZIN, BM
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1988,
43
(02)
: 158
-
158
[5]
SERUM LIPOPROTEIN CONCENTRATIONS IN CYSTIC-FIBROSIS
VAUGHAN, WJ
论文数:
0
引用数:
0
h-index:
0
机构:
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
VAUGHAN, WJ
LINDGREN, FT
论文数:
0
引用数:
0
h-index:
0
机构:
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
LINDGREN, FT
WHALEN, JB
论文数:
0
引用数:
0
h-index:
0
机构:
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
WHALEN, JB
ABRAHAM, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
CHILDRENS HOSP, MED CTR, BRUCE LYON MEM RES LAB, OAKLAND, CA 94609 USA
ABRAHAM, S
SCIENCE,
1978,
199
(4330)
: 783
-
786
[6]
PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS
KELLY, HB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEW MEXICO, COLL PHARM, CTR CYST FIBROSIS TREATMENT, ALBUQUERQUE, NM 87131 USA
KELLY, HB
MENENDEZ, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEW MEXICO, COLL PHARM, CTR CYST FIBROSIS TREATMENT, ALBUQUERQUE, NM 87131 USA
MENENDEZ, R
FAN, L
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEW MEXICO, COLL PHARM, CTR CYST FIBROSIS TREATMENT, ALBUQUERQUE, NM 87131 USA
FAN, L
MURPHY, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEW MEXICO, COLL PHARM, CTR CYST FIBROSIS TREATMENT, ALBUQUERQUE, NM 87131 USA
MURPHY, S
JOURNAL OF PEDIATRICS,
1982,
100
(02)
: 318
-
321
[7]
VARIABILITY OF TOBRAMYCIN PHARMACOKINETICS IN CYSTIC-FIBROSIS
MUNZENBERGER, PJ
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PHARMACEUT SCI,DETROIT,MI 48202
MUNZENBERGER, PJ
COMMISSARIS, RL
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PHARMACEUT SCI,DETROIT,MI 48202
COMMISSARIS, RL
MASSOUD, N
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PHARMACEUT SCI,DETROIT,MI 48202
MASSOUD, N
HSU, MC
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PHARMACEUT SCI,DETROIT,MI 48202
HSU, MC
PEDIATRIC INFECTIOUS DISEASE JOURNAL,
1987,
6
(08)
: 739
-
743
[8]
TOBRAMYCIN PHARMACOKINETICS IN CYSTIC-FIBROSIS - COMMENT
FRASER, GL
论文数:
0
引用数:
0
h-index:
0
FRASER, GL
DRUG INTELLIGENCE & CLINICAL PHARMACY,
1987,
21
(09):
: 755
-
755
[9]
EFFICACY OF INHALED TOBRAMYCIN IN CYSTIC-FIBROSIS
SEMSARIAN, C
论文数:
0
引用数:
0
h-index:
0
SEMSARIAN, C
JOURNAL OF PAEDIATRICS AND CHILD HEALTH,
1990,
26
(02)
: 110
-
111
[10]
AEROSOLIZED TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS
ASHBY, BL
论文数:
0
引用数:
0
h-index:
0
ASHBY, BL
STERN, DH
论文数:
0
引用数:
0
h-index:
0
STERN, DH
NEW ENGLAND JOURNAL OF MEDICINE,
1993,
329
(22)
: 1659
-
1660
←
1
2
3
4
5
→